Gaba told CNBC-TV18, "I have Ranbaxy in my portfolio. I like the stock, the level around Rs 300 is a good structure, and the way it's climbing from here looks like it can go to Rs 380-400 levels. It's a matter of time, so why not buy some more and take it up."
